Beatrice Coppadoro

Dr. Beatrice Coppadoro

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Audiology Research
Verified
Journal Article
Open access
PDF file
SCStefano Concheri
Stefano Concheri
DBDavide Brotto
Davide Brotto
MAMarzia Ariano
Marzia Ariano
Antonio DaloisoAntonio Daloiso
Antonio Daloiso
Valerio Maria Di Pasquale FiascaValerio Maria Di Pasquale Fiasca
Valerio Maria Di Pasquale Fiasca
SFSEBASTIANO FRANCHELLA
SEBASTIANO FRANCHELLA
Objectives: The objectives were to present the real-time estimated values of cochlear implant (CI) electrode insertion speed (IS) during intraoperative sessions using the Cochlear Nucleus SmartNav System to assess whether this measure affected CI outcomes and to determine whether real-time feedback assists expert surgeons in achieving slow insertion. Methods: The IS was measured in 52 consecutive patients (65 implanted ears) using the CI632 electrode. The IS values were analyzed in relation to procedure repetition over time, NRT ratio, and CI audiological outcomes. Results: The average IS was 0.64 mm/s (SD = 0.24); minimum and maximum values were 0.23 and 1.24 mm/s, respectively. The IS significantly decreased with each array insertion by the operator (p = 0.006), and the mean decreased by 24% between the first and last third of procedures; however, this reduction fell within the error range of SmartNav for IS (+/−0.48 mm/s). No correlation was found between IS and the NRT ratio (p = 0.51), pure-tone audiometry (PTA) at CI activation (p = 0.506), and PTA (p = 0.94) or word recognition score (p = 0.231) at last evaluation. Conclusions: The estimated IS reported by SmartNav did not result in a clinically significant reduction in insertion speed or an improvement in CI hearing outcomes. Real-time feedback of IS could potentially be used for training, but its effectiveness requires confirmation through additional studies and more accurate tools. Implementation of IS assessment in clinical practice will enable comparisons between measurement techniques and between manual and robot-assisted insertions. This will help define the optimal IS range to achieve better cochlear implant (CI) outcomes.

13 September 2025 in European Journal of Cancer
Verified
Journal Article
Closed access
FMFederico Mercolini
Federico Mercolini
MSMonika Sparber-Sauer
Monika Sparber-Sauer
LMLeo Mascarenhas
Leo Mascarenhas
JMJohannes H.M. Merks
Johannes H.M. Merks
EKEwa Koscielniak
Ewa Koscielniak
GBGianni Bisogno
Gianni Bisogno

15 November 2024 in Head & Neck
Verified
Journal Article
Open access
RSReineke A. Schoot
Reineke A. Schoot
PTPieter Taselaar
Pieter Taselaar
GSGiovanni Scarzello
Giovanni Scarzello
FKFrederic Kolb
Frederic Kolb
BCBeatrice Coppadoro
Beatrice Coppadoro
JMJohannes H.M. Merks
Johannes H.M. Merks
Background: Parameningeal (PM) site is an unfavorable characteristic in rhabdomyosarcoma (RMS). We described the treatment and outcome for patients with PM RMS and investigated the prognostic value of risk factors. We scored PM site by originating site and by highest risk extension.Methods: Patients with PM RMS were treated within the European pediatric Soft tissue sarcoma Study Group (EpSSG) RMS 2005 study with risk‐adapted, multi‐modal treatment.Results: Three‐hundred‐eighty‐one patients with PM RMS were included. Radiotherapy was administered in 359 patients (77 with surgery). After a median follow‐up of 75 months, 5‐year event‐free survival was 60% (95% confidence interval (CI) 55%–65%), 5‐year overall survival was 65% (95% CI 60%–70%).Conclusions: The outcome for patients with PM RMS has not improved in comparison to previous historical studies, despite the more rigorous application of radiotherapy (94% of patients). Signs of meningeal involvement, PM site, and age at diagnosis remained prognostic risk factors.Trial Registration: EudraCT number 2005‐000217‐35

4 June 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
BSBeatrice Serra
Beatrice Serra
SBsimona barni
simona barni
CVClaudia Valleriani
Claudia Valleriani
BCBeatrice Coppadoro
Beatrice Coppadoro
FCFrancesco Catamerò
Francesco Catamerò
Francesca MoriFrancesca Mori
Francesca Mori
Background/Objectives: Legume allergy is increasingly recognized as plant-based diets expand and legume proteins are widely used in processed foods. We aimed to characterize the clinical features, sensitization profiles, and management outcomes of IgE-mediated legume allergy in Italian children. Methods: This retrospective single-center study (January 2022–January 2024) included children (<18 years) allergic to ≥1 index legume (pea, lentil, chickpea, common bean, or soy). Diagnosis required a compatible clinical history and evidence of IgE sensitization. Clinical and allergy characteristics were analyzed. Results: Fifty-five children (63.6% male) were included; all had atopic comorbidities, and 96.4% had additional food allergies. Median age at first reaction was 18 months; anaphylaxis occurred at onset in 12.7%, most frequently triggered by pea. Pea (70.9%) and lentil (69.1%) were the most prevalent allergies, with pea causing 50% of index-legume anaphylaxis. Multi-legume allergy predominated (74.5%), with frequent co-allergy among pea, lentil, and chickpea (56–86%). Soy allergy was less frequent and mainly associated with Gly m 4 sensitization. Single-legume allergy (25.5%) was associated with later onset (54 vs. 15 months; p = 0.013) and liver transplantation (21% vs. 2%; p = 0.047). Peanut co-allergy occurred in 25.5%. Among 34 oral food challenges (OFCs), 23.5% were positive, including one case of pea-induced anaphylaxis. Of 16 oral immunotherapy (OIT) protocols initiated, 31.3% reached the full target maintenance dose, 37.5% remained on a lower, partial maintenance dose, and 31.3% were discontinued due to oral allergy syndrome (OAS). Conclusions: Pediatric legume allergy is characterized by early onset, frequent multi-legume involvement, and common co-allergies. In this cohort, pea allergy was associated with the highest proportion of severe reactions. Species-specific differences in severity, patterns of multi-legume involvement, and OIT outcomes should be interpreted cautiously given the limited sample size, while highlighting the need for tailored management and improved risk assessment across legume species.

27 April 2026 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
NSNaima Smeulders
Naima Smeulders
MGMark N. Gaze
Mark N. Gaze
FGFlorent Guérin
Florent Guérin
TRTimothy Rogers
Timothy Rogers
SSSheila Terwisscha van Scheltinga
Sheila Terwisscha van Scheltinga
HMHélène Martelli
Hélène Martelli
Risk stratification of rhabdomyosarcoma (RMS) requires accurate staging, with histological nodal assessment being of critical importance for specific tumour sites. This report explores the value of surgical nodal staging in bladder-prostate rhabdomyosarcoma (BP-RMS). Patients with BP-RMS enrolled in the RMS2005 and MTS2008 trials (2005-2016) were reviewed for the staging methodology and outcome. Significant differences in 5-year overall and progression-free survival were observed for the 224 patients with BP-RMS of different Tumour-Node-Metastasis (TNM) stages (p < 0.0001). Nodal staging was by imaging in all but 7/224 (3.1%) patients at presentation. Despite the opportunity for nodal sampling at surgery in 175 patients, no nodes were obtained in 120/175 (68.6%). Nodal sampling at surgery after 4-8 chemotherapy cycles in 48 patients, identified tumour in 6/37 (16.2%) patients considered N0 by imaging (all aged 5 cm tumours) and observed no tumour in 8/11 (72.7%) deemed N1, prompting changes to local therapy in 9/14 (64.3%). Overall, surgical nodal assessment did not impact on local/nodal progression/relapse (12/55, 21.8%) as compared to staging by imaging alone (29/166, 16.9%, p = 0.548; data missing for 3 patients). Pathological nodal assessment also failed to show benefit on locoregional events for patients with significantly poorer outcome, namely those aged ≥10 years (p = 0.446) or with unfavourable histology (p = 0.613). The specific targeting of nodal basins by radiotherapy showed no impact on outcome (p = 1.000). In contrast to other sites, surgical nodal sampling, undertaken in 24.6% (in 3.1% at diagnosis), does not significantly impact outcome of BP-RMS, despite imaging-pathological discordance prompting changes to treatment for affected patients.